Want to see HK:2502 full AI Analyst Report?
Top Page
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
(2502)
Select Model
Select Model
Rating:49Neutral
Price Target:
HK$0.57
▲(31.86% Upside)
Action:Reiterated
Date:07/11/26
The score is held down primarily by weakened financial performance (recent losses, margin compression, and a 2025 revenue decline). Technicals are moderately supportive with price above major moving averages, but mixed momentum limits the lift. Valuation is also a headwind because the negative P/E reflects loss-making results and no dividend yield support is available in the data.
Positive Factors
Moderate Leverage and Solid Equity Base
A manageable debt burden and substantial equity base provide financial resilience through industry cycles. This supports continued operations and preserves flexibility to fund recovery without relying excessively on new borrowing.
Negative Factors
Sustained Losses and Margin Compression
Two consecutive loss-making years indicate a material deterioration in earnings quality rather than a single isolated setback. Persistent gross-margin pressure could weaken reinvestment capacity and delay any return to sustainable shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Moderate Leverage and Solid Equity Base
A manageable debt burden and substantial equity base provide financial resilience through industry cycles. This supports continued operations and preserves flexibility to fund recovery without relying excessively on new borrowing.
Read all positive factors
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$995.06M
Dividend Yield3.05%
Average Volume (3M)51.80K
Price to Earnings (P/E)21.5
Beta (1Y)0.36
Revenue Growth-4.75%
EPS GrowthN/A
CountryHK
Employees392
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.02
Shares Outstanding955,640,000
10 Day Avg. Volume133,800
30 Day Avg. Volume51,800
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)0.39
Price to Sales (P/S)0.14
P/FCF Ratio5.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Henan Jinyuan Hydrogenated Chemicals Co., Ltd., based in Jiyuan, China, and established in 2012, primarily focuses on the manufacturing, processing, distribution, and sale of both hydrogenated benzene-derived chemicals and various energy commoditi...
How the Company Makes Money
null...
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
54
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.68B | 2.60B | 3.10B | 2.33B | 2.30B | 1.48B |
| Gross Profit | 121.00M | 30.88M | 71.64M | 148.80M | 285.51M | 142.80M |
| EBITDA | 160.14M | 64.12M | 77.03M | 163.47M | 294.84M | 168.50M |
| Net Income | 22.59M | -33.39M | -16.04M | 54.92M | 138.23M | 72.47M |
Balance Sheet | ||||||
| Total Assets | 1.52B | 1.52B | 1.68B | 1.66B | 1.08B | 971.94M |
| Cash, Cash Equivalents and Short-Term Investments | 347.69M | 357.55M | 352.62M | 300.71M | 92.47M | 50.08M |
| Total Debt | 280.58M | 290.06M | 338.27M | 262.97M | 165.30M | 51.17M |
| Total Liabilities | 428.33M | 446.60M | 584.85M | 535.95M | 355.88M | 418.55M |
| Stockholders Equity | 987.41M | 951.54M | 985.37M | 1.02B | 573.79M | 457.93M |
Cash Flow | ||||||
| Free Cash Flow | 66.68M | 72.66M | 13.82M | -43.95M | 199.74M | 44.27M |
| Operating Cash Flow | 107.99M | 114.76M | 96.86M | 104.46M | 318.82M | 94.88M |
| Investing Cash Flow | -29.78M | -41.12M | -268.86M | -71.06M | -150.12M | -58.70M |
| Financing Cash Flow | -90.29M | -68.09M | 2.49M | 204.95M | -139.06M | -44.28M |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis
Neutral
0.43
Price Trends
0.60
Negative
0.59
Positive
0.52
Positive
Market Momentum
<0.01
Negative
48.05
Neutral
79.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Neutral. The current price of 0.43 is below the 20-day moving average (MA) of 0.61, below the 50-day MA of 0.60, and below the 200-day MA of 0.52, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 48.05 is Neutral, neither overbought nor oversold. The STOCH value of 79.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2502.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | HK$1.48B | 6.91 | 5.15% | 6.10% | 6.66% | 65.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | HK$11.66B | 0.29 | 5.20% | 7.55% | 1.18% | 1119.31% | |
57 Neutral | HK$9.89B | -20.46 | -3.56% | 0.39% | 13.49% | -34.73% | |
49 Neutral | HK$995.06M | 21.54 | 2.33% | 3.05% | -4.75% | ― | |
49 Neutral | HK$3.17B | -2.57 | -51.09% | 1.64% | 11.19% | -3035.78% | |
45 Neutral | HK$3.30B | -178.40 | -8.09% | 2.18% | 3.15% | 50.74% |
* Basic Materials Sector Average
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.60
0.13
26.60%
HK:0336
Huabao International Holdings
3.07
-1.36
-30.62%
HK:0408
Yip's Chemical Holdings
2.63
0.91
52.88%
HK:3318
China Boton Group Co., Ltd.
2.94
0.96
48.48%
HK:0546
Fufeng Group Limited
4.65
-4.23
-47.66%
HK:0301
SANVO Fine Chemicals Group Limited
7.02
5.73
448.05%
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events
Henan Jinyuan Hydrogenated Chemicals Swings Back to Profit on Stronger Margins
Aug 26, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported interim unaudited revenue of RMB1.54 billion for the six months ended 30 June 2026, up from RMB1.44 billion a year earlier, with gross profit rising sharply to RMB112.8 million. Profit attrib...
Henan Jinyuan Signals Profit Turnaround on Strong Margins
Aug 19, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has issued a positive profit alert, indicating it expects to post an unaudited profit of about RMB41.6 million for the six months ended 30 June 2026, compared with a loss of roughly RMB9.3 million a y...
Henan Jinyuan Sets Board Meeting to Review Interim Results and Consider Dividend
Aug 14, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has scheduled a board meeting for 26 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026 for the company and its subsidiaries. The board als...
Henan Jinyuan Wins Unanimous Backing for Board and Supervisor Reappointments
Jul 24, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. secured overwhelming shareholder support at its 24 July extraordinary general meeting, with all votes cast in favour of reappointing eight directors, including executive, non-executive and independent...
Henan Jinyuan Hydrogenated Chemicals Calls EGM to Renew Board and Supervisory Mandates
Jul 8, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has called an extraordinary general meeting for 24 July 2026 in Hong Kong to seek shareholder approval on a slate of corporate governance matters. Shareholders are encouraged to vote via proxy rather ...
Henan Jinyuan Sets July 2026 EGM for Board and Supervisory Committee Election
Jul 6, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced that the current terms of its directors and supervisors will expire with the end of the present board and supervisory committee session. The company will elect a new board and supervisor...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.